2 recruiting, 1 completed. 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Remedy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MDMA-Assisted CBCT for PTSD vs CBCT RCT MDMA assisted psychotherapy, Psychotherapy - Post Traumatic Stress Disorder | Phase 2 | Recruiting | Remedy | 60 | 2024-11-15 | 2026-08-19 |
| Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial Methotrexate, TNF Inhibitor - Juvenile Idiopathic Arthritis | Phase 4 | Recruiting | Oslo University Hospital | 150 | 2024-10-24 | 2026-10-19 |
| A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD) MDMA - Post Traumatic Stress Disorder | Phase 2 | Completed | Remedy | 10 | 2021-10-04 | 2024-11-14 |
Stress Disorders, Post-Traumatic (2) · Arthritis, Juvenile (1)
Methotrexate (1) · N-Methyl-3,4-methylenedioxyamphetamine (1) · Psychotherapy (1) · Tumor Necrosis Factor Inhibitors (1)
Canada (2) · Norway (1)
Anne Wagner, PhD (2) · Alison Bruni, MD (1) · Anna-Birgitte Aga, MD PhD (1) · Paul Uy, MD (1)